X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
female (49) 49
index medicus (45) 45
middle aged (40) 40
adult (36) 36
male (35) 35
oncology (26) 26
aged (23) 23
public, environmental & occupational health (22) 22
environmental sciences (21) 21
immunotherapy (19) 19
melanoma (19) 19
animals (16) 16
cancer (16) 16
breast cancer (14) 14
poland (13) 13
research (13) 13
genetic aspects (11) 11
adolescent (10) 10
dust (10) 10
genetics (10) 10
history (10) 10
work-related symptoms (10) 10
allergy (9) 9
ipilimumab (9) 9
organic dust (9) 9
agriculture (8) 8
brca1 (8) 8
breast neoplasms - genetics (8) 8
cell biology (8) 8
families (8) 8
metastatic melanoma (8) 8
mice (8) 8
mutation (8) 8
occupational exposure (8) 8
occupational exposure - adverse effects (8) 8
original paper (8) 8
ovarian cancer (8) 8
pantoea agglomerans (8) 8
skin tests (8) 8
therapy (8) 8
agricultural workers' diseases - etiology (7) 7
cancer vaccines (7) 7
care and treatment (7) 7
farmers (7) 7
fungi (7) 7
genes, brca1 (7) 7
health aspects (7) 7
life sciences (7) 7
poland - epidemiology (7) 7
poland politics and government (7) 7
treatment outcome (7) 7
aged, 80 and over (6) 6
agricultural workers' diseases - immunology (6) 6
airborne microorganisms (6) 6
antigens, bacterial - immunology (6) 6
chemistry (6) 6
disease (6) 6
endotoxin (6) 6
gene (6) 6
history and criticism (6) 6
immunology (6) 6
melanoma - drug therapy (6) 6
metallurgy (6) 6
neoplasms. tumors. oncology. including cancer and carcinogens (6) 6
ovarian neoplasms - genetics (6) 6
polish literature (6) 6
politics and government (6) 6
prevalence (6) 6
risk factors (6) 6
spirometry (6) 6
air microbiology (5) 5
allergens (5) 5
analysis (5) 5
bacteria (5) 5
case-control studies (5) 5
drug therapy (5) 5
dust - analysis (5) 5
erwinia-herbicola (5) 5
gene mutations (5) 5
herbs (5) 5
hypersensitivity pneumonitis (5) 5
lncrna (5) 5
medicine (5) 5
mice, inbred c57bl (5) 5
organic dusts (5) 5
pathology (5) 5
prostate cancer (5) 5
respiratory function tests (5) 5
women (5) 5
abridged index medicus (4) 4
acyclic or carbocyclic compounds (4) 4
aerosols (4) 4
allergens - immunology (4) 4
biography (4) 4
biomarker (4) 4
breast neoplasms - pathology (4) 4
breast-cancer (4) 4
chek2 (4) 4
clinical trials (4) 4
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (15) 15
UTL at Downsview - May be requested (15) 15
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Petro Jacyk (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


细胞研究:英文版, ISSN 1001-0602, 2015, Volume 25, Issue 2, pp. 208 - 224
Journal Article
Cell Research, ISSN 1001-0602, 02/2015, Volume 25, Issue 2, pp. 208 - 224
The cytotoxic T lymphocyte antigen-4 (CTLA-4)-blocking antibody ipilimumab induces immune-mediated long-term control of metastatic melanoma in a fraction of... 
sCD25 | tumor immunotherapy | ipilimumab | IL-2 | cancer | CTLA-4 blockade | Original | CD122
Journal Article
JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN 2051-1426, 11/2018, Volume 6, Issue 1, pp. 134 - 8
BackgroundAGI-101H is an allogeneic gene modified whole cell therapeutic melanoma vaccine, evaluated in over 400 melanoma patients in the adjuvant and... 
COLONY-STIMULATING FACTOR | Melanoma | TUMOR | Long-term survivals | IMMUNOLOGY | COMBINATION | Phase II clinical trials | Genetic melanoma vaccine | GENE | ONCOLOGY | DESIGNER CYTOKINE | Immunotherapy | PROSTATE-CANCER | CHECKPOINT | Re-induction | BLOCKADE | IPILIMUMAB | Care and treatment | Diagnosis | Dendritic cells | Surgery | Stem cells | Clinical trials | Metastasis | Prostate cancer | Tumors
Journal Article
1997, Zeszyty katyńskie, ISBN 838648232X, Volume nr 7, 2 v. in 1 (496 p.)
Book
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2017, Volume 21, Issue 1, pp. 1 - 5
The treatment landscape of advanced melanoma has changed significantly following the discovery and marketing authorisation of immune checkpoints inhibitors.... 
Immunotherapy | Melanoma | Anti-PD1 | Medical prognosis | Apoptosis | melanoma | anti-PD1 | Review Paper | immunotherapy
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2017, Volume 2, Issue 1A, pp. 68 - 72
The treatment landscape in advanced melanoma is changing dramatically with the approval of new drugs. Vemurafenib was the first approved targeted agent for the... 
BRAF inhibitors | MEK inhibitors | Melanoma | melanoma | Review
Journal Article
Medicine, ISSN 0025-7974, 12/2014, Volume 93, Issue 27, p. e157
About 40% to 60% of melanomas present BRAF mutation. Selective BRAF inhibitors such as vemurafenib and dabrafenib are currently approved for the treatment of... 
MEDICINE, GENERAL & INTERNAL | GEFITINIB | BRAF | RETREATMENT | INHIBITOR | PROGRESSION | Neoplasm Metastasis | Skin Neoplasms - drug therapy | Humans | Melanoma - drug therapy | Middle Aged | Drug Resistance, Neoplasm | Female | Antineoplastic Agents - administration & dosage | Indoles - administration & dosage | Sulfonamides - administration & dosage
Journal Article
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, ISSN 1871-5206, 2019, Volume 19, Issue 5, pp. 580 - 586
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 616 - 622
Journal Article
CELLS, ISSN 2073-4409, 04/2019, Volume 8, Issue 4, p. 366
Background: Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease with high mortality. The identification of specific HNSCC biomarkers will... 
lncRNA | METASTASIS | non-coding RNA | LONG-NONCODING RNA | ZFAS1 | PROLIFERATION | biomarker | head and neck cancers | CANCER | CELL BIOLOGY | EPITHELIAL-MESENCHYMAL TRANSITION | INVASION | HNSCC | POOR-PROGNOSIS | ZNFX1 antisense RNA 1 | PROMOTES | EXPRESSION | EIF4E
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2012, Volume 16, Issue 3, pp. 197 - 200
The 2012 ASCO (American Society of Clinical Oncology) annual meeting has beer held once again at the McCormick Conference Center in Chicago, Illinois, where... 
Cancer vaccines | BRAF inhibitor | MEK inhibitor | Kinase inhibitors | Immunotherapy | Melanoma | kinase inhibitors | ONCOLOGY | cancer vaccines | immunotherapy | melanoma | Original Paper
Journal Article
Medicine (United States), ISSN 0025-7974, 12/2014, Volume 93, Issue 27
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2012, Volume 16, Issue 5, pp. 363 - 370
The incidence of melanoma is increasing steadily both in Poland and worldwide. Until 2010 three drugs were approved for the treatment of metastatic melanoma -... 
Cancer vaccines | BRAF inhibitor | Anti-CTLA4 | Immunotherapy | Melanoma | SURVIVAL | DENDRITIC CELLS | cancer vaccines | melanoma | BRAF | DACARBAZINE | COMBINATION | anti-CTLA4 | METASTATIC MELANOMA | THERAPY | ONCOLOGY | immunotherapy | MUTATIONS | CLINICAL-RESPONSE | IPILIMUMAB | Review
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.